Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

http://www.wikidata.org/entity/Q36738118

about

microRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's Disease The biomarkers of immune dysregulation and inflammation response in Parkinson disease Emerging preclinical pharmacological targets for Parkinson's disease Neuronal dark matter: the emerging role of microRNAs in neurodegeneration Ageing and Parkinson's disease: why is advancing age the biggest risk factor?Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies Modulation of cellular signaling pathways in P23H rhodopsin photoreceptors.Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity.Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice Chaperone-mediated autophagy: roles in disease and aging.Autophagy and human disease: emerging themes.MicroRNA control of high-density lipoprotein metabolism and function The Interplay between Alpha-Synuclein Clearance and Spreading Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases.microRNA Profiles in Parkinson's Disease Prefrontal Cortex Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.TRPV1 activation impedes foam cell formation by inducing autophagy in oxLDL-treated vascular smooth muscle cells.Chaperone-mediated autophagy: dedicated saviour and unfortunate victim in the neurodegeneration arena.Defective autophagy in Parkinson's disease: lessons from genetics.MicroRNAs as Mediators of the Ageing Process.Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders.Sirtuins and proteolytic systems: implications for pathogenesis of synucleinopathies.Genes associated with Parkinson's disease: regulation of autophagy and beyond.Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases.microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways.Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?Targeted suppression of chaperone-mediated autophagy by miR-320a promotes α-synuclein aggregation.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson's Disease.miRNAs as biomarkers of neurodegenerative disorders.Specific small-RNA signatures in the amygdala at premotor and motor stages of Parkinson's disease revealed by deep sequencing analysis.Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats.Glutamine promotes Hsp70 and inhibits α-Synuclein accumulation in pheochromocytoma PC12 cells.Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.

P2860

Q26738440-77985DD4-1560-4E93-B35C-4A23DD09BC80 Q26738459-E3ECCC7F-0A0A-4F63-9FFD-7A7C743CC23F Q26764724-563DA7E1-A200-4059-A605-1D80975B5D23 Q26859224-9C89EC47-8B0A-479E-9B8B-DCB7FF2245B2 Q27021628-1B8A763E-09C5-4EB4-9D0A-80EF8002F460 Q28080047-75280131-1224-4AFE-A334-61E69440E16D Q33715640-C7BC5EB5-DEA3-44B3-A39F-6F3FAAFA11ED Q33852777-F76108B9-BEFA-4750-8A0C-778DED751003 Q34004577-24689291-10D4-45E9-9D1B-F84A3A6085BE Q34376186-FD505980-EB92-423C-9F7B-5A85041C1D56 Q34388237-5BEF6512-C89A-4C5D-B6E9-8DBEEE094089 Q34620377-2835F638-CCAC-4883-89F2-D584E0786C1B Q35200081-A3ED3691-AF6E-4E02-8CB5-A541DA858D4C Q35833984-5D981539-13FC-45B3-84FF-93B174534C9A Q36100277-B0D34B58-E463-4E74-90C9-E3C7DBAB1C7A Q36634755-E67698EC-5787-4090-B533-658BA64DA03A Q36810948-8933DA85-ECDB-4235-899F-CF3FA15BD018 Q37325908-2D0CE22C-47A8-4A62-94A9-361C14F5A5FA Q37726111-A538AFDD-F2D5-4E42-BA39-345DFB8FB488 Q38164376-39372381-FE2B-49B8-B6A8-8367EF4FC0D0 Q38225786-164C112F-AA91-4571-A039-AACA496B5AF6 Q38241604-F3606F08-497B-4993-AAF1-F18D58A85CDF Q38365159-764F2C8E-8051-4ED9-9483-FF9DC70CC15C Q38462113-1470AD23-4C5D-4D65-8FCF-FD630ED85D79 Q38557027-47846E98-9D84-440F-ACAD-E540B2B0C570 Q38584755-3AFEE623-D0AE-43EA-BCFD-4BA6BE71ABFD Q38635154-32A41765-B005-431E-85FA-989813DF42A7 Q38648154-D4FEC190-2E79-44C5-A750-DE14509D53B9 Q38709419-487A434B-C7B7-450F-BE27-2B3F018BE2E7 Q38727638-95712E73-C66E-47C8-93CE-A6B10615A45A Q38765856-61570302-46FB-4F5B-AD46-350D36727FAE Q38843644-56F04635-EBC6-4CC0-BBCB-4D53D1FF0631 Q38957827-CCF1EB17-B8AC-4C78-8192-34CC5A53F351 Q39010887-81654AE6-61CB-4551-AA1A-B620C53B9F74 Q39075686-E0980DCA-FB25-422E-912A-DEB47AB116DB Q39104808-6E2A9A88-B2F2-4671-99CA-2726B49BFA31 Q40360134-C2BCA1AE-8F3F-40B3-8F2E-EDEDEBFB1965 Q40501958-CBACF986-4EA7-4062-923E-97935CB112A2 Q41113409-1C338E7B-5F1F-4BA4-9091-09327E70000A Q41574315-76D34DE6-A311-425A-AC56-561AA373E38F

P2860

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

http://www.wikidata.org/entity/Q36738118

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Influence of microRNA deregula ...... hology in Parkinson's disease.

@ast

Influence of microRNA deregula ...... hology in Parkinson's disease.

@en

type

label

Influence of microRNA deregula ...... hology in Parkinson's disease.

@ast

Influence of microRNA deregula ...... hology in Parkinson's disease.

@en

prefLabel

Influence of microRNA deregula ...... hology in Parkinson's disease.

@ast

Influence of microRNA deregula ...... hology in Parkinson's disease.

@en

P1433

Q36738118-0FB41162-680C-4AB9-B4E2-AD2B80247329

P1476

Q36738118-7B4EECFB-64B1-40CB-9FF4-384370CF1F66

P2093

Q36738118-11111C8B-8153-4F73-B34B-3CB331FDABC4

Q36738118-B0E200F8-0481-4CBC-A7CE-423DE5396FC4

Q36738118-FFF93616-1E6B-49EC-8B4C-F87E66321ECB

P2860

Q36738118-04700E5B-00F2-43AD-955D-10C4E6B49ED6

Q36738118-0631AC6C-49E3-4024-9D27-52C52E77F018

Q36738118-07390D7A-7E77-4A27-B853-B236D8463F82

Q36738118-12087BC6-06B7-4CB2-9A87-B98130672F26

Q36738118-160CDAC0-FE01-454E-BEC3-720C8A591652

Q36738118-20A3BD76-5408-4911-A8DC-133358F28C15

Q36738118-26A80BA1-7B70-40E4-8269-1483E47159BD

Q36738118-284EABB9-8DC4-4533-AEB3-6CFAFF380506

Q36738118-2F02A79E-6207-4290-9FF0-52595A721F0E

Q36738118-42452506-6366-42BA-9968-43EF1448AE25

P304

Q36738118-88E4305D-A8CF-4AA1-8B41-45661E7EB1D2

P31

Q36738118-3A2A90CE-6A21-4DBB-9394-BCE932F2261B

P356

Q36738118-2082BEFD-DEE6-428A-BF36-08E03C8C3D11

P478

Q36738118-9C6A22DB-4B00-40CB-953F-166D290BBD3B

P50

Q36738118-63AC2CD7-B32B-43AE-BB76-D2932D482920

Q36738118-B99FD057-29F4-492D-A48B-AD2346475FAE

Q36738118-D6789674-9D44-4396-9B2B-678CC1894772

P577

Q36738118-1F2342AC-FC07-458E-8FE1-117F122E7A76

P5875

Q36738118-5ADCA6E8-5FBA-4EB9-9A76-D48CB8E2C478

P698

Q36738118-CB86D100-AF9B-4ED7-9696-ABE133CAAFF8

P921

Q36738118-415C8BD3-AFE2-4C99-A160-A10C60616A66

Q36738118-67D21D84-6900-42B1-A047-77F3C4CDDFB5

Q36738118-6DB5FD21-72CF-420F-91F3-BA924F18D59F

Q36738118-8BF0883A-32FA-4600-87B8-B2D273FB4630

Q36738118-FD0E9612-6D9B-4F65-A26E-3125DB194AD0

P932

Q36738118-94512D4D-6A3F-492A-8550-5E5FA5F7A9FB

P356

P1433

Cell Death and Disease

P1476

Influence of microRNA deregula ...... thology in Parkinson's disease

@en

P2093

A H V Schapira

http://www.w3.org/2001/XMLSchema#string

J A Obeso

http://www.w3.org/2001/XMLSchema#string

J M Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

The RIN: an RNA integrity number for assigning integrity values to RNA measurements

Parkinson's Disease: Genetics and Pathogenesis

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis

Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

alpha-Synuclein locus triplication causes Parkinson's disease

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

P304

e545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2013.73

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Maria Cruz Rodriguez Oroz

P577

2013-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236047267

http://www.w3.org/2001/XMLSchema#string

P698

23492776

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

molecular chaperones

P932

3615743

http://www.w3.org/2001/XMLSchema#string